ritanserin has been researched along with Dysthymia in 1 studies
Ritanserin: A selective and potent serotonin-2 antagonist that is effective in the treatment of a variety of syndromes related to anxiety and depression. The drug also improves the subjective quality of sleep and decreases portal pressure.
ritanserin : A thiazolopyrimidine that is 5H-[1,3]thiazolo[3,2-a]pyrimidin-5-one which is substituted at position 7 by a methyl group and at position 6 by a 2-{4-[bis(4-fluorophenyl)methylidene]piperidin-1-yl}ethyl group. A potent and long-acting seratonin (5-hydroxytryptamine, 5-HT) antagonist of the subtype 5-HT2 (Ki = 0.39 nM), it is used in the treatment of a variety of disorders including anxiety, depression and schizophrenia. It has little sedative action.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Pharmacotherapy for dysthymia appears to be an effective short-term treatment for dysthymic disorder." | 2.42 | Benefits and risks of pharmacotherapy for dysthymia: a systematic appraisal of the evidence. ( De Lima, MS; Hotopf, M, 2003) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| De Lima, MS | 1 |
| Hotopf, M | 1 |
1 review available for ritanserin and Dysthymia
| Article | Year |
|---|---|
Benefits and risks of pharmacotherapy for dysthymia: a systematic appraisal of the evidence.
Topics: Antidepressive Agents; Antidepressive Agents, Tricyclic; Dibenzocycloheptenes; Dysthymic Disorder; H | 2003 |